Pfizer
PFE
$38.76
Share price
0.30%
Change (1 day)
-27.22%
Change (1 year)
Categories
Pfizer Inc., is a global pharmaceutical company headquartered in New York City, New York, United States. It was founded by Charles Pfizer from Ludwigsburg. Pfizer is the second largest pharmaceutical company in the world after Roche, followed by Novartis.
Pfizer (PFE) - P/B ratio
P/B ratio as of June 2023 : 2.27
According to Pfizer's latest financial reports the company has a price-to-book ratio of 2.27.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Pfizer - P/B ratio (from 2001 to 2022)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2022-12-31 | 3.00 | -29.92% |
| 2021-12-31 | 4.28 | 32.74% |
| 2020-12-31 | 3.22 | -5.67% |
| 2019-12-31 | 3.42 | -12.69% |
| 2018-12-31 | 3.91 | 29.9% |
| 2017-12-31 | 3.01 | -8.53% |
| 2016-12-31 | 3.29 | 7.41% |
| 2015-12-31 | 3.07 | 12.08% |
| 2014-12-31 | 2.74 | 6.96% |
| 2013-12-31 | 2.56 | 14.5% |
| 2012-12-31 | 2.23 | 10.96% |
| 2011-12-31 | 2.01 | 26.67% |
| 2010-12-31 | 1.59 | -2.07% |
| 2009-12-31 | 1.62 | -21.53% |
| 2008-12-31 | 2.07 | -12.36% |
| 2007-12-31 | 2.36 | -8.74% |
| 2006-12-31 | 2.59 | -1.15% |
| 2005-12-31 | 2.62 | -11.13% |
| 2004-12-31 | 2.94 | -28.61% |
| 2003-12-31 | 4.12 | -56.34% |
| 2002-12-31 | 9.44 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 5.37 | 136.53% | 🇺🇸 USA |
 Novartis NVS | 4.06 | 78.75% | 🇨🇭 Switzerland |
 Abbott Laboratories ABT | 4.85 | 113.83% | 🇺🇸 USA |
 Eli Lilly LLY | 37.2 | 1,538.28% | 🇺🇸 USA |
 Amgen AMGN | 22.0 | 871.37% | 🇺🇸 USA |
 Merck MRK | 6.15 | 171.21% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | 4.32 | 90.57% | 🇺🇸 USA |
 AstraZeneca AZN | 6.38 | 181.05% | 🇬🇧 UK |
 GlaxoSmithKline GSK | 5.05 | 122.44% | 🇬🇧 UK |